3-bis(4-Methylbenzoyloxy)succinate)
|
|
|
- CAS-Nr.
- 477600-71-8
- Englisch Name:
- 3-bis(4-Methylbenzoyloxy)succinate)
- Synonyma:
- (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid compd. with (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine;3R)-2;BAP-L-Tartrate;4R)-1-benzyl-N;Tofacitinib Impurity 170;Tofacitinib Intermediate I;Tofacitinib intermediate 1;-2,3-bis((4-methylbenzoyl);3-bis(4-Methylbenzoyloxy)succinate);4-diMethylpiperidin-3-aMine heMi((2R
- CBNumber:
- CB72616053
- Summenformel:
- C34H40N2O8
- Molgewicht:
- 604.7
- MOL-Datei:
- 477600-71-8.mol
|
3-bis(4-Methylbenzoyloxy)succinate) Eigenschaften
- storage temp.
- Inert atmosphere,Room Temperature
- Aussehen
- White to off-white Solid
- InChIKey
- KSSMVGPZPYBDAC-RQHPIBCPNA-N
- SMILES
- [C@@H](C(=O)O)(OC(C1C=CC(C)=CC=1)=O)[C@H](C(=O)O)OC(C1C=CC(C)=CC=1)=O.C(C1C=CC=CC=1)N1CC[C@@H](C)[C@@H](NC)C1 |&1:0,14,38,40,r|
3-bis(4-Methylbenzoyloxy)succinate) Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
3-bis(4-Methylbenzoyloxy)succinate) is a valuable organic compound that can be used in laboratory research and development processes and chemical and pharmaceutical synthesis processes.
3-bis(4-Methylbenzoyloxy)succinate) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-bis(4-Methylbenzoyloxy)succinate) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 154)Lieferanten
477600-71-8()Verwandte Suche:
- 3-bis(4-Methylbenzoyloxy)succinate)
- 4-diMethylpiperidin-3-aMine heMi((2R
- 4R)-1-benzyl-N
- (3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-aMine heMi((2R,3R)-2,3-bis((4-Methylbenzoyl)oxy)succinate)
- Bis[(3R,4R)-1-benzyl-N,4-diMethylpiperidin-3-aMine]di-p-toluyl-L-tartrate
- Butanedioic acid, 2,3-bis[(4-Methylbenzoyl)oxy]-, (2R,3R)-, coMpd. with (3R,4R)-N,4-diMethyl-1-(phenylMethyl)-3-piperidinaMine (1:2)
- Bis[(3R,4R)-N,4-diMethyl-1-(phenylMethyl)-3-piperidinaMine] di-p-toluyl-L-tartrate
- (3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-aMine ((2R,3R)-2,3-bis((4-Methylbenzoyl)oxy)succinate) (2:1)
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine (2S,3S)-2,3-bis((4-Methylbenzoyl)oxy)succinic acid
- Tofacitinib Intermediate I
- (2R,3R)-2,3-bis(4-methylbenzoyloxy)butanedioic acid
- bis((3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine)
- (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine,(2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid
- Bis[(3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine] di-p-toluoyl-L-tartrate
- Tofacitinib intermediate 1
- -1-Benzyl-N,4-dimethylpiperidin-3-amine ((2R,3R)
- -2,3-bis((4-methylbenzoyl)
- (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine-(-)-Di-p-toluoyl-(L)-tartaric acid monohydrate salt
- (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]
- (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid and (3R, 4R) -N, 4-dimethyl-1- (phenylmethyl) 3-Piperidine amine compound
- (3R,4R)-1-benzyl-N-dimethylpiperidin-3-amine (1:2)
- (3-R,4R)1-1BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE (2R,3R)-2,3-BIS(4-METHYLBENZOYL)OXY)SUCCINATE
- 3-bis(4-Methylbenzoyloxy)succinate) tert-butyl ester
- Bis (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine di Toluyl L-Tartrate
- (2R,3R)-2,3-Bis[(4-
methylbenzoyl)oxy]succinic acid -
(3R,4R)-1-benzyl-N,4-dimethyl-
3-piperidinamine (1:2)
- Tofacitinib Impurity 170
- hemi((2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid)
- 3R)-2
- (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid compd. with (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine
- BAP-L-Tartrate
- (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine (1:2)
- hemi((2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid) - [B15038]
- (2R,3R)-2,3-pair [(4-Methylbenzoyl)Oxygen]Succinic acid and (3R,4R)-N,4-dimethyl- 1-(phenylmethyl)-3-Piperidinamine compounds
- (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid and (3R,4R)-N,N-dimethyl-1-(phenylmethyl)piperidin-3-amine compound
- 477600-71-8
- C20H18O82C14H22N2
- 209-5B
